Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Sulkowski

Showing results (51-60 of 206) with videos related to

Pageof 21
Sort By:
AIDS (London, England)|December 4, 2004
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavirMark S Sulkowski, Shruti H Mehta, Richard E Chaisson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2016
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infectionJordan J Feld, Ira M Jacobson, Mark S Sulkowski, et al.
AIDS (London, England)|October 28, 2005
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug usersShruti H Mehta, David L Thomas, Mark S Sulkowski, et al.
Antiviral Therapy|March 16, 2012
Stability of liver fibrosis among HCV-infected injection drug usersShruti H Mehta, Gregory D Kirk, Jacquie Astemborski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Increased Mortality Among Persons With Chronic Hepatitis C With Moderate or Severe Liver Disease: A Cohort StudyJavier A Cepeda, David L Thomas, Jacquie Astemborski, et al.
Journal of Viral Hepatitis|November 22, 2019
Nurse case management to improve the hepatitis C care continuum in HIV co-infection: Results of a randomized controlled trialLaura E Starbird, Chakra Budhathoki, Hae-Ra Han, et al.
Research in Nursing & Health|August 29, 2018
Care2Cure: A randomized controlled trial protocol for evaluating nurse case management to improve the hepatitis C care continuum within HIV primary careLaura E Starbird, Hae-Ra Han, Mark S Sulkowski, et al.
The Lancet. HIV|December 25, 2019
Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIVRobert C Bollinger, Chloe L Thio, Mark S Sulkowski, et al.
Annals of Internal Medicine|March 22, 2016
Antimicrobial Access in the 21st Century: Delays and Critical ShortagesShmuel Shoham, Annukka A R Antar, Paul G Auwaerter, et al.
Journal of Virological Methods|April 10, 2025
High-dimensional droplet digital PCR of multiple hepatitis B splice variants in serum, liver, and tissue cultureTanner Grudda, Chenkai Jiang, Che-Min Lo, et al.
Pageof 21

Showing results (51-60 of 206) with videos related to

Sort By:
Pageof 21
AIDS (London, England)|December 4, 2004
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavirMark S Sulkowski, Shruti H Mehta, Richard E Chaisson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2016
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infectionJordan J Feld, Ira M Jacobson, Mark S Sulkowski, et al.
AIDS (London, England)|October 28, 2005
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug usersShruti H Mehta, David L Thomas, Mark S Sulkowski, et al.
Antiviral Therapy|March 16, 2012
Stability of liver fibrosis among HCV-infected injection drug usersShruti H Mehta, Gregory D Kirk, Jacquie Astemborski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Increased Mortality Among Persons With Chronic Hepatitis C With Moderate or Severe Liver Disease: A Cohort StudyJavier A Cepeda, David L Thomas, Jacquie Astemborski, et al.
Journal of Viral Hepatitis|November 22, 2019
Nurse case management to improve the hepatitis C care continuum in HIV co-infection: Results of a randomized controlled trialLaura E Starbird, Chakra Budhathoki, Hae-Ra Han, et al.
Research in Nursing & Health|August 29, 2018
Care2Cure: A randomized controlled trial protocol for evaluating nurse case management to improve the hepatitis C care continuum within HIV primary careLaura E Starbird, Hae-Ra Han, Mark S Sulkowski, et al.
The Lancet. HIV|December 25, 2019
Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIVRobert C Bollinger, Chloe L Thio, Mark S Sulkowski, et al.
Annals of Internal Medicine|March 22, 2016
Antimicrobial Access in the 21st Century: Delays and Critical ShortagesShmuel Shoham, Annukka A R Antar, Paul G Auwaerter, et al.
Journal of Virological Methods|April 10, 2025
High-dimensional droplet digital PCR of multiple hepatitis B splice variants in serum, liver, and tissue cultureTanner Grudda, Chenkai Jiang, Che-Min Lo, et al.
Pageof 21